V020-4473 Screening compound: 1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-1,3-benzodiazole

V020-4473 Screening compound: 1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-1,3-benzodiazole
V020-4473 Screening compound: 1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-4473
1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-4473

Molecular Formula

C24H34N4O2 (C24 H34 N4 O2)

Compound Name

1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-1,3-benzodiazole

IUPAC name

1-(cyclohexylmethyl)-2-[4-(morpholine-4-carbonyl)piperidin-1-yl]-1H-13-benzodiazole

SMILES

O=C(C(CC1)CCN1c1nc(cccc2)c2n1CC1CCCCC1)N1CCOCC1

InChI

InChI=1S/C24H34N4O2/c29-23(26-14-16-30-17-15-26)20-10-12-27(13-11-20)24-25-21-8-4-5-9-22(21)28(24)18-19-6-2-1-3-7-19/h4-5,8-9,19-20H,1-3,6-7,10-18H2

InChI Key

RCBWPSZNKQLIKT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968695

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

410.56

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.426

Distribution Coefficient, logD

4.417

Water Solubility, LogSw

-4.35

Polar Surface Area

37.909

Acid Dissociation Constant (pKa)

21.91

Base Dissociation Constant (pKb)

8.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

66.70

V020-4473 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nucleic Acid Ligands (8311 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V020-4473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-4473?
Check Price and Availability of V020-4473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-4473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-4473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-4473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-4473 available by request